Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
View ORCID ProfileRajith KR Rajoli, Henry Pertinez, View ORCID ProfileUsman Arshad, Helen Box, Lee Tatham, View ORCID ProfilePaul Curley, View ORCID ProfileMegan Neary, Joanne Sharp, View ORCID ProfileNeill J Liptrott, Anthony Valentijn, Christopher David, View ORCID ProfileSteve P Rannard, View ORCID ProfileGhaith Aljayyoussi, View ORCID ProfileShaun H Pennington, Andrew Hill, View ORCID ProfileMarta Boffito, Stephen A Ward, View ORCID ProfileSaye H Khoo, Patrick G Bray, Paul M. O’Neill, W. Dave Hong, View ORCID ProfileGiancarlo Biagini, View ORCID ProfileAndrew Owen
doi: https://doi.org/10.1101/2020.05.01.20087130
Rajith KR Rajoli
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Henry Pertinez
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Usman Arshad
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Helen Box
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Lee Tatham
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Paul Curley
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Megan Neary
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Joanne Sharp
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Neill J Liptrott
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Anthony Valentijn
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Christopher David
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Steve P Rannard
2Department of Chemistry, University of Liverpool, Liverpool, L69 3BX, UK
Ghaith Aljayyoussi
3Centre for Drugs and Diagnostics. Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
Shaun H Pennington
3Centre for Drugs and Diagnostics. Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
Andrew Hill
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Marta Boffito
4Chelsea and Westminster NHS Foundation Trust and St Stephen’s AIDS Trust 4th Floor, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
5Jefferiss Research Trust Laboratories, Department of Medicine, Imperial College, London, W2 1PG, UK
Stephen A Ward
3Centre for Drugs and Diagnostics. Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
Saye H Khoo
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Patrick G Bray
6Pat Bray Electrical, 260D Orrell Road, Orrell, Wigan, WN5 8QZ, UK
Paul M. O’Neill
2Department of Chemistry, University of Liverpool, Liverpool, L69 3BX, UK
W. Dave Hong
2Department of Chemistry, University of Liverpool, Liverpool, L69 3BX, UK
Giancarlo Biagini
3Centre for Drugs and Diagnostics. Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK
Andrew Owen
1Department of Molecular and Clinical Pharmacology, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK
Data Availability
The data referred to in the manuscript has been cited accordingly as recorded in the references section of the manuscript
Posted May 06, 2020.
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith KR Rajoli, Henry Pertinez, Usman Arshad, Helen Box, Lee Tatham, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher David, Steve P Rannard, Ghaith Aljayyoussi, Shaun H Pennington, Andrew Hill, Marta Boffito, Stephen A Ward, Saye H Khoo, Patrick G Bray, Paul M. O’Neill, W. Dave Hong, Giancarlo Biagini, Andrew Owen
medRxiv 2020.05.01.20087130; doi: https://doi.org/10.1101/2020.05.01.20087130
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis
Rajith KR Rajoli, Henry Pertinez, Usman Arshad, Helen Box, Lee Tatham, Paul Curley, Megan Neary, Joanne Sharp, Neill J Liptrott, Anthony Valentijn, Christopher David, Steve P Rannard, Ghaith Aljayyoussi, Shaun H Pennington, Andrew Hill, Marta Boffito, Stephen A Ward, Saye H Khoo, Patrick G Bray, Paul M. O’Neill, W. Dave Hong, Giancarlo Biagini, Andrew Owen
medRxiv 2020.05.01.20087130; doi: https://doi.org/10.1101/2020.05.01.20087130
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2826)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12526)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4405)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2835)
- Health Policy (1044)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4161)
- Nursing (220)
- Nutrition (615)
- Oncology (2190)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (264)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6743)
- Radiology and Imaging (1483)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (362)
- Surgery (471)
- Toxicology (57)
- Transplantation (198)
- Urology (173)